This is an external research project funded by @cancersociety.bsky.social and any information you choose to provide will be managed by the study team. For more information, visit www.canpact.ca/projects
The survey aims to identify the most important unanswered questions regarding the use of psychedelic-assisted therapies and ensure that future research reflects the priorities of the people most affected.
This survey takes about 15 min to complete: survey.ucalgary.ca/jfe/form/SV_...
Join a national survey on psychedelic-assisted cancer therapies!
The Canadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT) is inviting people affected by cancer, caregivers, clinicians and policymakers to take part in a survey regarding psychedelic-assisted cancer care.
REMINDER: Join us April 14 for an Environmental Sustainability in Research webinar exploring connections between climate, health systems and #cancer #research.
To register, email research@cancer.ca
How can #science become more #sustainable? Join us for an Environmental Sustainability in Research webinar exploring connections between climate, health systems and #cancer #research. Featuring speakers from OHRI, UOttawa, CASCADES & CCS.
April 14, 1–2:30pm ET
To register, email research@cancer.ca
Join us in our journey to help understand, prevent, detect and treat #cancer through cutting-edge Canadian #ClinicalTrials.
🗓️ The program launches officially on April 22 – watch this space!
💻 Find out more on the program’s web page: cancerresearchsociety.ca/funding-prog...
Led by @src-crs.bsky.social with co-leads @cancersociety.bsky.social & @terryfoxresearch.bsky.social , in collaboration with Lotte & John Hecht Memorial Foundation, @genomequebec.bsky.social @kindredfoundation.bsky.social & Childhood Cancer Canada, this investment will reshape the future of cancer.
Clinical trials are changing!
Today, @cancersociety.bsky.social and partners are announcing a brand-new funding program for investigator-initiated #cancer #ClinicalTrials. The goal: enable Canadian researchers to lead groundbreaking trials that reshape the cancer landscape in #Canada and worldwide.
For the first time, TFRI is investing directly in cancer prevention, partnering with CIHR & CCS, and investing $10M to support projects that deepen our understanding of cancer development and advance early detection and risk reduction.
Learn more: tinyurl.com/a2untpve
Together, @cancersociety.bsky.social , its funding partners, these experts and their teams are turning groundbreaking research projects into a future where #cancer prevention is more proactive, more personalized and more accessible – allowing us to stop cancer before it starts.
Finally, CCS and @terryfoxresearch.bsky.social are funding Dr Alberto Martin, who is researching a common gut microbe to understand its link to #cancer. He and his team will study how dietary fibre and supplements affect the microbe and its connection to #ColonCancer and other growths in the colon.
In partnership with @terryfoxresearch.bsky.social , CCS is supporting Dr Vincent Fradet’s research into how #ProstateCancer and gut bacteria affect one another. This work may lead to new ways of predicting #cancer and may even lead to new treatments that can reduce the aggressiveness of the disease.
Co-funded by CCS and the CIHR Institute of Population and Public Health, Dr Aaron Goodarzi is studying #LungCancer risk factors. His team will research factors like indoor air #pollution, radon data and genetics to understand people’s exposure and risk – as well as these cancers’ economic costs.
In partnership with the CIHR Institute of Nutrition, Metabolism and Diabetes, CCS is supporting Dr Rachel Murphy’s research into whether ultra-processed foods cause #ColonCancer. The team will also study how these foods affect gut bacteria and how changes to the gut bacteria may affect #cancer.
In a third project co-funded by CCS and the CIHR ICR, Dr Christopher Maxwell and colleagues are studying whether a drug used to stop milk production after pregnancy can help prevent #BreastCancer in people with mutations that increase their risk – paving the way for a #ClinicalTrial.
Also in partnership with the CIHR ICR, CCS is funding Dr Luke McCaffrey and his team in understanding why some lesions become #BreastCancer and others don’t – allowing people who need #cancer treatment to receive it quickly and those who don’t to avoid unnecessary procedures and side effects.
In partnership with the CIHR Institute of #Cancer Research (ICR), CCS is supporting Dr Mark Basik’s work on better #BreastCancer screening for young women. Using AI-assisted imaging and genomics, they aim to understand which people would benefit from specialized screening or preventive treatment.
Up to 40% of #cancers are preventable – and new #research can help us stop cancer before it starts. That’s why, together, @cancersociety.bsky.social and partners are funding 7 teams committed to preventing cancer, reducing risk and improving early detection and diagnosis in Canada and worldwide.
An international collaboration to prevent #cancer!
Today @cancersociety.bsky.social , CIHR, @terryfoxresearch.bsky.social , the Japan Agency for Medical Research & Development, the Cancer Research Society & @biocanrx.bsky.social are investing $41.5 million to change the future of cancer prevention.
Today, Dr Demers and his team are updating the country’s most important data on workplace related #LungCancer to strengthen protections for workers in Canada now and in the future.
Learn more about his #research and see how you can help create a future without #cancer: bit.ly/460lZPe
@cancersociety.bsky.social -funded researcher Dr Paul Demers has spent more than 30 years uncovering how workplaces increase people’s risk of #cancer and transforming that evidence into meaningful, practical change. His #research has helped influence major policy decisions to help prevent cancer.
REMINDER: Deadline to submit abstracts for the Research Training Awards is February 18!
Learn more: cancer.ca/en/research/...
REMINDER: Call for nominations for @cancersociety.bsky.social Advisory Council on Research (ACOR).
We’re looking for #researchers and people with lived or living #cancer experience to join our ACOR and help guide #research programs and priorities.
Deadline is Feb 27.
Nominate here: is.gd/sMS7iN
@cancersociety.bsky.social -funded research is changing how people with #cancer are treated worldwide. We’re proud to see @myesmo.bsky.social #ClinicalPracticeGuideline update recommending structured exercise for people with #ColonCancer.
Learn more about this @cctg.bsky.social trial: is.gd/ojV6cY
Research trainees! Join our virtual IGNITE Workshop on Advocacy & Government Relations.
Learn how advocacy and storytelling drive impact in #cancer #research with @cancersociety.bsky.social Advocacy leaders Jasmine Brown & Dylan Buskermolen.
📅 Feb 6, 12 pm ET
Email research@cancer.ca to sign up.
Calling Canadian #ClinicalTrials investigators! You may be eligible for @cctg.bsky.social’s VISION Investigator Leadership Training. This 8-month program includes workshops, group discussions and personalized coaching.
Applications due January 30.
Learn more: www.ctg.queensu.ca/public/visio...
Day 1 (Jan 22) of the #HealthEquity in Cancer Research Symposium features workshops led by Drs Ambreen Sayani, Zhimeng Jia, Anna Pujadas Botey & Jagbir Kaur.
On Day 2 (Jan 28), #research teams across Canada will present their work in health equity followed by breakout rooms for group conversation.
Join our 2-part virtual Health Equity in Cancer Research Symposium! Explore how to apply #HealthEquity in #cancer #research and connect with teams across Canada. All team members are welcome!
📅 Jan 22 & 28, 2026 | 12:30–3:30 PM ET
Register here:
Day 1: is.gd/UAnaxj
Day 2: is.gd/lW0I7O
We have 8 #researcher vacancies and 3 for people with lived #cancer experience starting June 2026. Seeking members from diverse backgrounds, career stages, geography, age, gender, race and cancer experience.
👉 Nomination deadline: February 27 - 5 p.m. ET
Learn more: cancer.ca/en/research/...
CALL FOR NOMINATIONS: @cancersociety.bsky.social Advisory Council on Research
We’re looking for #researchers and people with lived or living #cancer experience to join our Advisory Council on Research (ACOR) and help guide #research programs and priorities.
Nominate here: is.gd/sMS7iN
